Clinical Trials Browser

Phase 1/2 × Lymphoma, Extranodal NK-T-Cell × Cisplatin × Clear all

NCT03246750 2024-04-17

B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma

Phase 1/2 Completed

Lymphoma, Extranodal NK-T-Cell